logo
How Brown University's Pandemic Tracker is filling a gap in federal health data

How Brown University's Pandemic Tracker is filling a gap in federal health data

Boston Globe21-07-2025
Nuzzo told the Globe how the Pandemic Tracker, which has nearly 10,000 subscribers, has become a go-to resource for
Get Rhode Island News Alerts
Sign up to get breaking news and interesting stories from Rhode Island in your inbox each weekday.
Enter Email
Sign Up
Q. The
has garnered public attention. Why do you think people look to the newsletter for information?
Advertisement
Nuzzo:
People are worried about potential threats and what it means for them. They're looking for trusted information and unfortunately these days I think people are questioning whether the information coming out of our health agencies is correct. ... One of the reasons why we are also tracking this information is because there had been … a lot of change in terms of what data federal health agencies were sharing. We decided to start going directly to state health departments for information.
Advertisement
Pandemic Center Director Jennifer Nuzzo at a meeting for a new edition of the Tracking Report. Foreground: Research Assistant Alice Im.
Kenneth Zirkel
How has data changed since COVID-19?
Where I do see a difference is that the
How is the information you present different than the CDC website?
I don't want to give the sense something nefarious is happening. It's not nefarious. Where we have concerning discrepancies is in interpretation of data. There's a period of time where the Secretary of Health and Human Services, Robert F. Kennedy Jr., when getting questions about these
Initially, the CDC was only showing a very cursory summary of measles cases. It wasn't showing the breakdown, whether they're hospitalized, or you know, the vaccination status. ... There's now better data on CDC's website, but initially there wasn't. Part of why we're doing this exercise is if something changes we're ready to fill in the gaps.
Why is it so surprising that this measles outbreak is happening?
United States eliminated measles in 2000. There is no good reason why any country with the technical and financial resources of the United States should have measles, period. It's not to say that other countries haven't struggled with measles outbreaks — they have — including, other high-income countries like us, but measles elimination status is determined by how quickly you respond and contain the outbreaks.
Advertisement
The latest Pandemic Tracker highlights measles, mpox, avian influenza, cholera, seasonal influenza, COVID-19, and pertussis. What is the importance of tracking these diseases?
It's based on what's going on in the world. For instance, a few months ago, we were very actively tracking
Are you seeing an influx of people
who are craving good, scientific information?
I think there's always going to be a role for independent expert voices.
People want to hear from people in their community. I do think, now, that people are very worried about the integrity of our health agencies, about funding cuts that make it harder to do the important work and research that keeps people healthy. ... The American people, despite the headlines, trust scientists, they value scientific research, and they want more of it.
On the Pandemic Tracker website, you have a program called
. Talk about the global pandemic early warning system intended to 'rapidly detect future outbreaks of infectious diseases with epidemic or pandemic potential?'
It's part of the Global Health Exemplars Program. We're studying really interesting approaches to surveillance in four low- and middle-income countries. What we're learning is applicable to all countries, but these are countries who are doing things
with surveillance that are starting to allow them not to just understand when an outbreak happens and figure that out early, but perhaps to give them a better sense of what are the conditions that make outbreaks more likely to occur. And then, perhaps, take action to prevent them from occurring in the first place.
Advertisement
Can you talk a little bit about use of wastewater testing?
I think one important innovation that came out of the pandemic … is wastewater surveillance and the increased understanding of it as a potential tool for monitoring infections in a community. We are now using wastewater to monitor other things: influenza, mpox, and it's now just starting to be used for measles. We have been seeing signals of measles infections in states that hadn't yet reported measles cases. This is important because we think that measles cases are being under-detected in the US and wastewater data is giving us even more indication of that.
On the site there is a 'testing playbook' for biological emergencies. Can you share more about preparedness and response to these emergencies?
If we have to think of what's the single biggest thing that went wrong in the US response to COVID, it was that we didn't quickly establish and scale up the availability of testing. It was a well-acknowledged challenge and yet in 2022 when the mpox outbreaks started happening in the United States, yet again, we were hearing clinicians saying, 'I can't get my patient tested.' There were tests available, but it just wasn't where the patients were. We decided to write the testing playbook to better clarify the different approaches to testing to give busy decision-makers a better set of questions to be asking in response to a biological emergency.
Advertisement
Here are a few ways to follow Brown University SPH's Pandemic Tracker:
Pandemic Center
Pandemic Center
Tracking Report Newsletter
This interview has been edited for length and clarity.
The Boston Globe's weekly Ocean State Innovators column features a Q&A with Rhode Island innovators who are starting new businesses and nonprofits, conducting groundbreaking research, and reshaping the state's economy. Send tips and suggestions to reporter Alexa Gagosz at
.
Carlos Muñoz can be reached at
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare
Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

Yahoo

time29 minutes ago

  • Yahoo

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

The global concierge medicine market size is expected to be worth USD 39.02 billion by 2034, up from USD 21.77 billion in 2025 and is projected to register an impressive CAGR of 6.7% during the forecast period from 2025 to 2034. This growth is primarily driven by the rising demand for personalized and preventive healthcare services, as patients increasingly seek direct access to physicians, longer consultation times, and improved care continuity. Ottawa, July 28, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the concierge medicine market size has been accounted for USD 21.77 billion in 2025 and is predicted to rise from USD 23.23 billion in 2026 to approximately USD 39.02 billion by 2034. During 2025 to 2034, the market is expected to grow at a solid CAGR of 6.70%. The increased need for concierge medicine is driven by the emphasis on personalized and preventive care and improved patient satisfaction. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for Before You Buy – Get the Sample Report@ Quick Insights: Concierge Medicine Market Key Takeaways In terms of revenue, the global concierge medicine market was valued at USD 20.40 billion in 2024. It is anticipated to reach over USD 39.02 billion by 2034. The market is poised to grow at a notable compound annual growth rate (CAGR) of 6.70% from 2025 to 2034. North America accounted for the largest market share of 43% in 2024. Asia Pacific is expected to grow at the fastest CAGR between 2025 and 2034. By application, the primary care contributed the highest market share of 27.3% in 2024. By application, the pediatrics segment is expected to grow at a strong CAGR from 2025 to 2034. By ownership, the group segment held the major market share of 64% in 2024. By ownership, the independent segment is expected to grow at the fastest CAGR during the forecast period. Concierge Medicine Market Overview and Industry Potential What is Concierge Medicine? Concierge medicine refers to the association between patients and physicians through which special care is provided to patients who reserve high-end premium packages in advance. It involves payments in the form of monthly or annual fixed fees for same-day appointments or 24/7 physician availability. This package encompasses pediatricians, urgent care clinics, house calls of the doctor, medical specialists, or primary care physicians. The healthcare professionals involved in these packages generally set their special appointments to visit and care only for their concierge service patients. Also Read @ How Concierge Medicine Complements the Precision Medicine Revolution in the U.S. Concierge medicine is redefining the patient-provider relationship by enabling faster, more personalized care,' said Rohan Patil, Principal Consultant at Precedence Research. 'As healthcare shifts toward individualized service models, this market is poised for transformative growth. Concierge Medicine Market Major Trends: What are the Major Trends in Concierge Medicine and Healthcare Membership? Integration of Telehealth: There is an integration of telehealth into concierge practices which is coupled with technological advancements and acceptance of virtual visits. It has resulted in increased utilization of resources and adherence to quality measures like accreditation. Telehealth assists in treating injuries, illness, and promotes longevity. Quality Care: For this purpose, several healthcare professionals such as nurse practitioners, membership models, concierge physician specialties, etc. are involved in concierge medicine practices. They impact access, the levels of quality of care, and cost. These practices ensure a balanced quality of care for patients. Discover the Complete Findings@ Concierge Medicine Market Growth Factors Why Should Patients Choose Concierge Services? No more Hurried Visits: People do not feel that their medical visits are going to be rushed due to the high workload of healthcare workers. Physicians stick to a strict appointment timeline to see every patient who needs medical care. Direct Access to Healthcare Provider: Patients undergoing medical care through concierge service packages experience good availability and accessibility of medical providers. The patients are always a priority of their healthcare professionals. What is the Role of the Cutting-edge Artificial Intelligence in the Concierge Medicine Market? Artificial Intelligence powered tools assist in image recognition, where they can analyze medical images with high precision. They can also identify abnormalities in the human body through medical images that cannot be seen through the human eye. These approaches are very useful in the dermatology and radiology fields. AI is not only enhancing image diagnostics but also powering personalized treatment planning, remote patient monitoring, and intelligent scheduling. Concierge platforms are leveraging AI chatbots for 24/7 communication, predictive analytics for early disease detection, and tailored wellness plans based on biometric data. MORE FOR YOU: ➢ AI in Healthcare Market Size, AI-Powered Diagnostics & Enhancing Accuracy ➢ How AI Is Reshaping Medical Imaging: A $14.46 Billion Market Opportunity by 2034 ➢ Medical Imaging on the Rise: Market Growth, Key Segments & Regional Outlook Opportunities in the Concierge Medicine Market In December 2024, Sollis Health announced the investment of $33 million in series B funding to boost product innovation, member experience, and expansion across the nation. (Source: In November 2024, Bajaj Finserv Health announced the investment of INR 1,000 Crore in technology and services to launch 'Health Saathi' concierge. (Source: Concierge Medicine Market Challenges and Limitations: What are the Key Problems associated with Concierge Medicine? Out-of-Pocket Costs: Personalized healthcare is related to its own price tag and patients feel a prohibitive membership fee. These out-of-pocket services may not be included under the prescriptions, concierge umbrella-like specialist visits, and hospital stays. Challenging Insurance Billing: Patients can face issues regarding transparency in healthcare services and insurance billing. This process involves endless phone calls, policies, and vague responses that can leave patients more baffled than informed. Out-of-pocket membership fees typically range between USD 1,500 to USD 5,000 annually in the U.S., depending on the level of service. This pricing model can limit access for middle-income populations and may not be covered by traditional insurance models. Also Read@ Why Hospitals Are Outsourcing Billing: Insights Into the USD 54 B Market Boom Scope of Concierge Medicine Market Report Attributes Statistics Market Size in 2024 USD 20.40 Billion Market Size in 2025 USD 21.77 Billion Market Size by 2034 USD 39.02 Billion Growth Rate (2025–2034) CAGR of 6.70% U.S. Market Size in 2025 USD 6.55 Billion U.S. Market Size in 2034 USD 1.97 Billion U.S. Market Growth Rate (2025–2034) CAGR of 6.88% Base Year 2024 Forecast Period 2025 to 2034 Dominant Market North America – due to higher adoption of retainer-based healthcare models Fastest Growing Region Asia Pacific – driven by rising demand for premium healthcare services Benefits for Buyers • Understand regional trends• Compare revenue share• Identify growth pockets and investment zones Segments Covered Application, Ownership, and Regions Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Top Companies Covered PartnerMD, Crossover Health, MDVIP, CONCIERGE CONSULTANTS & CARDIOLOGY, Signature MD, Peninsula Doctor, Winstead PC, Castle Connolly Private Health Partners, Specialdocs Consultants, LLC., Priority Physicians, Inc. Real‑World Case Studies: How Concierge Medicine Is Reshaping Healthcare 1) Human Longevity Clinic — Silicon Valley (2025) Case Summary:In early 2025, the Human Longevity Clinic in South San Francisco gained attention for offering ultra-premium, AI-integrated longevity plans priced between USD 8,000 and 19,000 per year. Patients undergo advanced diagnostics, including full-body MRIs, genome sequencing, cardiac scans, and blood panels, generating over 150GB of health data per client. Outcome Highlights: Detected early-stage aneurysms and tumors in asymptomatic patients. Personalized plans improved long-term prognosis through lifestyle interventions. AI tools assisted with anomaly detection, enhancing care quality beyond traditional diagnostics. Why It Matters:This example illustrates the growing appeal of preventive concierge models, blending precision diagnostics and tech-driven personalization. It aligns perfectly with your report's insights on AI integration, growing demand for preventive care, and willingness to pay for high-touch services. 2) Dr. Khalid Saeed's House Call Concierge Model — Tampa Bay, Florida (2023–2024) Case Summary:Dr. Khalid Saeed launched a concierge house-call practice offering personalized in-home and virtual care with monthly fees between USD 150–800, depending on patient complexity. His business model is insurance-free, catering to ~250 patients with 24/7 access. Outcome Highlights: Patients report dramatically reduced stress and stronger physician relationships. The practice operates profitably with minimal administrative burden. A blend of telehealth and in-person visits enables efficient chronic care management. Why It Matters:This model reflects the group and independent ownership trends cited in your report, showing how small-scale practices can thrive by offering personal, direct access to healthcare. It also supports your forecast for independent practices growing at the fastest CAGR during 2025–2034 Set up a meeting at your convenience to get more insights instantly! Concierge Medicine Market Regional Analysis: How North America Dominated the Concierge Medicine Market in 2024? North America dominated the concierge medicine market in 2024 owing to the increased demand for personalized care and chronic disease prevalence. This region is making efforts to accomplish its ambitious vision across infrastructure, health, science, tourism, technology, entertainment, and renewable energy. The U.S. makes partnerships with tech companies and investors to become a leader in next-generation technologies and digital infrastructure. Also Read@ Global Medical Tourism: How a USD 43.5 B Industry in 2025 Is Transforming Healthcare Trave How Big is the U.S. Concierge Medicine Industry? According to Precedence Research, the U.S. concierge medicine market size was valued at USD 6.14 billion in 2024 and is projected to reach USD 11.97 billion by 2034, growing at a CAGR of 6.88% from 2025 to 2034. Consumers are driving growth in this market by seeking personalized care, including direct physician access, longer consultations, and same- or next-day appointments, enabled by membership-based, low-patient-load models. U.S. Concierge Medicine Market – Key Takeaways By Application: The "Others" segment accounted for the largest market share in 2024, leading the U.S. concierge medicine landscape. Primary Care Segment: Expected to remain the second-largest application segment throughout the forecast period, demonstrating consistent demand and adoption. By Ownership: The group ownership model dominated the market in 2024, capturing the highest share among ownership types. Note: This Report is Readily Available for Immediate Delivery| Download the Sample Pages of this Report@ U.S. Concierge Medicine Market Top Companies Priority Physicians, Inc Castle Connolly Private Health Partners Partner MD Concierge Consultants and Cardiology U.S. Concierge Medicine Market Key Drivers: Physician Burnout & Shift in Practice Models: Many U.S. doctors are transitioning away from high-volume, insurance-based models to concierge practices to reduce administrative burdens and improve patient relationships. Consumer Demand for Better Access: Patients are willing to pay out-of-pocket fees (typically $1,500–$3,000/year) for longer appointments, direct communication, and same-day scheduling. Chronic Disease Prevalence: With rising cases of diabetes, obesity, and heart disease, concierge medicine allows for continuous care and lifestyle management that traditional practices often lack time for. Employer-Sponsored Concierge Care: Corporations are increasingly offering concierge medical services as a benefit to executives and high-performing employees, recognizing its value in reducing absenteeism and improving health outcomes. Japan Concierge Medicine Market Key Drivers: Aging Population & Chronic Disease Burden: With over 28% of Japan's population aged 65 and older, there is increasing demand for continuous care, home visits, and customized treatment plans, which concierge models are well-equipped to provide. Rising Interest in Preventive Health & Wellness: Japan's healthcare culture emphasizes longevity and wellness, aligning well with concierge medicine's focus on preventive screenings, lifestyle planning, and holistic care. High Expectations for Quality & Privacy: Wealthier patients and business executives in Japan are willing to pay premium fees for private, convenient, and responsive medical services, especially in metro areas like Tokyo, Osaka, and Yokohama. For instance, Tokyo-based startup 'PrimeDoc' launched a membership plan in 2024 targeting C-level executives and foreign residents, offering multilingual concierge services and AI-powered diagnostics. Corporate Adoption: Some high-end concierge services are being introduced by private hospitals and corporate health programs to cater to senior executives and foreign residents. For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@ How Asia Pacific is Moving towards Sustainable Development in 2025? Asia Pacific is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to rising disposable income and growing healthcare awareness. The Economic and Social Commission for Asia and the Pacific and the regional platform make efforts to empower, inform, and support Asian Pacific countries to achieve sustainable development goals. These countries include less developed countries, small island developing states, and landlocked developing countries. In February 2025, the Asia-Pacific Forum on Sustainable Development (APFSD) was organized to advance sustainable, science-based, evidence-based, and inclusive solutions for good health, well-being, gender equality, economic growth, and decent work. Concierge Medicine Market Segmentation Analysis: Application Analysis How Primary Care Segment Dominated the Concierge Medicine Market in 2024? The primary care segment dominated the concierge medicine market in 2024 owing to increased accessibility and convenience. Consumers are paying attention to personalized and preventive care, which also improves management of chronic conditions. One of the key drivers of this segment's growth is the rising consumer focus on preventive and proactive health management. Patients are no longer satisfied with reactive, episodic care; instead, they are seeking ongoing monitoring, wellness planning, and chronic disease management, all of which are core offerings in concierge primary care models. This approach is especially valuable for patients with conditions such as diabetes, hypertension, and cardiovascular issues, where continuity of care and close monitoring significantly impact outcomes. The pediatrics segment is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to proactive healthcare management. Pediatric care is available in the form of at-home convenience, personalized care, and healthcare attention. Also Read@ Population Health Management Market Set to Reach USD 625.9 B by 2034 – What's Fueling the Surge Ownership Analysis What made Group the Dominant Segment in the Concierge Medicine Market in 2024? The group segment dominated the concierge medicine market in 2024 owing to enhanced patient relationships and reduced administrative burden. Group ownership allows financial stability, predictability, scalability, and resource sharing. The independent segment is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to work-life balance and improved patient retention. It causes reduced reliance on insurance reimbursements and streamlined operations. Related Topics You May Find Useful: ➢ Artificial Intelligence (AI) In Precision Medicine Market: The global AI in precision medicine market size was accounted for USD 2.32 billion in 2024 and is anticipated to reach around USD 49.49 billion by 2034, growing at a CAGR of 35.80% from 2025 to 2034. ➢ Regenerative Medicine Market: The global regenerative medicine market size accounted for USD 35.80 billion in 2024 and is predicted to increase from USD 43.80 billion in 2025 to approximately USD 212.80 billion by 2034, expanding at a CAGR of 19.20% from 2025 to 2034. ➢ Complementary and Alternative Medicine Market: The global complementary and alternative medicine market size was valued at USD 154.69 billion in 2024 and is expected to reach over USD 1282.70 billion by 2034, poised to grow at a CAGR of 23.56% from 2025 to 2034. ➢ eHealth 2.0 Market: The global eHealth 2.0 market size accounted for USD 347.54 billion in 2024 and is predicted to increase from USD 381.36 billion in 2025 to approximately USD 879.55 billion by 2034, expanding at a CAGR of 9.73% from 2025 to 2034. ➢ Personalized Medicine Market: The global personalized medicine market was calculated at USD 614.22 billion in 2024 and is predicted to increase from USD 654.46 billion in 2025 to approximately USD 1,315.43 billion by 2034, expanding at a CAGR of 8.10% from 2025 to 2034. Concierge Medicine Market Leading Companies MDVIP SignatureMD Concierge Choice Physicians Crossover Health Specialdocs Consultants Castle Connolly Private Health Partners, LLC Peninsula Doctor Concierge Medicine HealthAssure Private Limited One Medical Priority Physicians of Carmel, Inc. UC San Diego Health What is Going Around the Globe? In September 2024, WhiteGlove announced the launch of AI-Enabled Medical Concierge to assist immigrants in caring for family living abroad. (Source: In October 2024, Sollis Health announced the launch of its first family membership that can recognize the needs of parents for an integrated emergency and everyday care company. (Source: Concierge Medicine Market Segments Covered in the Report By Application Primary Care Cardiology Pediatrics Psychiatry Internal Care Others By Ownership Independent Group By Region North America U.S. Canada Mexico Asia Pacific China Singapore Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa South Africa UAE Saudi Arabia Kuwait Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Stay Ahead with Precedence Research Subscriptions Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Trusted Data Partners: Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Get Recent News: For the Latest Update Follow Us: LinkedIn | Facebook | TwitterSign in to access your portfolio

Cutting-edge Diagnostic Technologies Transforming $6.4 Billion Landscape
Cutting-edge Diagnostic Technologies Transforming $6.4 Billion Landscape

Yahoo

time44 minutes ago

  • Yahoo

Cutting-edge Diagnostic Technologies Transforming $6.4 Billion Landscape

The U.S. Alzheimer's disease diagnostics market, valued at USD 3.53 billion in 2024, is projected to grow at a CAGR of 10.6% from 2025-2030. Growth is driven by rising Alzheimer's prevalence and advanced diagnostics like FDA-approved blood tests, improving early detection and care planning. U.S. Alzheimer's Disease Diagnostics Market Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By Type, By End-use, And Segment Forecasts, 2025 - 2030" report has been added to U.S. Alzheimer's disease diagnostics market was valued at USD 3.53 billion in 2024 and is expected to grow at a CAGR of 10.6% from 2025 to 2030 This growth is driven by the rising prevalence of Alzheimer's disease and increasing emphasis on early and accurate diagnosis. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 6.7 million older adults in the U.S. were living with Alzheimer's disease in 2024, a number projected to nearly double by 2060. The growing prevalence of the disease prompted government and private healthcare bodies to invest heavily in advanced diagnostic technologies such as PET imaging, cerebrospinal fluid biomarkers, and blood-based diagnostics. The growth of the U.S. Alzheimer's disease diagnostics market is due to the recent regulatory approval of advanced, non-invasive diagnostic technologies. The U.S. FDA granted marketing clearance for the first in vitro diagnostic device that utilizes a blood test to support the diagnosis of Alzheimer's disease. The Lumipulse G pTau217/b-Amyloid 1-42 Plasma Ratio is specifically intended for the early detection of amyloid plaque accumulation, a hallmark of Alzheimer's pathology, in adult patients aged 55 years and older who are exhibiting clinical signs and symptoms consistent with cognitive development represents a major advancement in Alzheimer's diagnostics, significantly lowering access barriers by providing a cost-effective and minimally invasive alternative to PET scans and lumbar punctures, which often carry procedural risks. The FDA highlighted that this approval makes it easier and potentially more accessible for U.S. patients earlier in the disease. It underscores the test's value in facilitating timely intervention and clinical decision-making in the early stages of Alzheimer's disease increasing rate of dementia diagnosis among older adults is driving the growth of the U.S. Alzheimer's diagnostics market. According to the 2022 National Health Interview Survey by the CDC, approximately 4% of individuals aged 65 and older have been diagnosed with dementia, with this figure rising to 13% among those aged 85 and above. This growth is primarily attributed to longer life expectancy, enhanced awareness, and improved diagnostic practices across clinical settings. The rising need for scalable, accurate diagnostic solutions to support early detection, appropriate intervention, and optimized care planning. Why should you buy this report? Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments. Competitive Landscape: Explore the market presence of key players worldwide. Future Trends: Discover the pivotal trends and drivers shaping the future of the global market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $3.53 Billion Forecasted Market Value (USD) by 2030 $6.43 Billion Compound Annual Growth Rate 10.6% Regions Covered United States Competitive Landscape GE HealthCare Siemens Healthineers AG Canon Medical Systems Corporation Cerveau Technologies, Inc. Neurovision Imaging, Inc. Thermo Fisher Scientific Inc. Bio-Rad Laboratories, Inc. Quanterix Corporation Alzheon Inc. NanoSomiX, Inc. DiamiR Biosciences Company Overview Financial Performance Diagnostic Technique Portfolio Recent Developments/ Strategic Initiatives U.S. Alzheimer's Disease Diagnostics Market Report SegmentationDiagnostic Technique Outlook (Revenue, USD Million, 2018 - 2030) Biomarkers CSF Biomarkers Blood-Based Biomarkers Imaging Diagnostic Techniques Genetic Testing Cognitive Assessment Tests Type Outlook (Revenue, USD Million, 2018 - 2030) Triage Diagnosis Screening End Use Outlook (Revenue, USD Million, 2018 - 2030) Hospitals Diagnostic Laboratories Academic & Research Institutes For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Alzheimer's Disease Diagnostics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio

Fearing Medicaid coverage loss, some parents rush to vaccinate their kids
Fearing Medicaid coverage loss, some parents rush to vaccinate their kids

CNN

time2 hours ago

  • CNN

Fearing Medicaid coverage loss, some parents rush to vaccinate their kids

For two decades, Washington, D.C., pediatrician Lanre Falusi has counseled parents about vaccine safety, side effects, and timing. But this year, she said, the conversations have changed. 'For the first time, I'm having parents of newborns ask me if their baby will still be able to get vaccines,' Falusi said. Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, especially those with children on Medicaid, the government insurance program for low-income families and people with disabilities. Medicaid covers 4 in 10 children in the U.S. 'It really became an issue when RFK Jr. stepped into the role of HHS secretary,' said Deborah Greenhouse, a pediatrician in South Carolina. The concern accelerated after the shake-up of a key Centers for Disease Control and Prevention vaccine advisory body in June, raising fears that millions of American families could soon have to pay out-of-pocket for shots now covered by their health insurance. Health and Human Services Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist, removed all 17 members of the CDC's Advisory Committee on Immunization Practices, the panel responsible for recommending which shots are included in the nation's adult and childhood immunization schedules. Kennedy replaced the panelists with new members aligned with his views, prompting alarm among medical professionals and public health experts. 'People should be worried about what's going to happen to the availability of vaccines for children,' said Jennifer Tolbert, deputy director of the Program on Medicaid and the Uninsured at KFF, a national health information nonprofit that includes KFF Health News. Under the Affordable Care Act, health insurers are required to cover all ACIP-recommended vaccines. States and other jurisdictions use the childhood vaccine schedule to set immunization requirements for schoolchildren. ACIP's recommendations also determine which vaccines get covered by the Vaccines for Children Program, a CDC-funded initiative that provides free immunizations to low-income and uninsured children. Half of children in the U.S. are eligible for the VFC program. If the new ACIP members withdraw support for a particular vaccine and the CDC director agrees, Tolbert said, the consequences would be immediate. 'It would automatically affect what is covered and therefore which vaccines are available to children on Medicaid,' she said. Health insurance companies have not yet said how they would alter coverage, but Tolbert said such a move would open the door for private insurers to refuse to cover the vaccine. Pediatricians worry about a future where parents might have to choose — pay hundreds of dollars out-of-pocket for shots or leave their kids unprotected. The health insurance industry group AHIP said that health plans 'continue to follow federal requirements related to coverage of ACIP-recommended vaccines and will continue to support broad access to critical preventive services, including immunizations.' Pediatricians say news about President Donald Trump's new budget law, which is expected to reduce Medicaid spending by about $1 trillion over the next decade, also prompted questions from parents. While parents may be worried about losing their Medicaid, the law doesn't mention vaccines or change eligibility or benefits for children's Medicaid, Tolbert said. But less federal funding means states will have to make decisions about who is covered and which services are offered. To raise the revenue needed to pay for Medicaid, states could raise taxes; move money earmarked for other spending, such as education or corrections; or, more likely, reduce Medicaid spending. 'And they may do that by cutting eligibility for optional populations or by cutting services that are optional, or by reducing payments to providers in the form of provider rates,' Tolbert said. 'It's unclear how this will play out, and it will likely look different across all states.' In May, Kennedy announced in a post on X that the CDC is no longer recommending the covid-19 vaccine for healthy children and pregnant women. The move prompted a lawsuit by the American Academy of Pediatrics and other physician groups that seeks to freeze Kennedy's directive. In June, the new ACIP members appointed by Kennedy voted to recommend that adults and children no longer receive flu vaccines with thimerosal, a preservative rarely used in some flu vaccines. Anti-vaccine activists, including Kennedy, have rallied against thimerosal for decades, alleging links to autism despite no evidence of any association. 'There is no cause for concern,' Department of Health and Human Services spokesperson Emily Hilliard said in a statement. 'As Secretary Kennedy has stated, no one will be denied access to a licensed vaccine if they choose to receive one.' 'When the ACIP committee met last month, they reaffirmed that flu vaccines will remain accessible and covered, and they emphasized safety by ensuring these vaccines are mercury-free,' Hilliard wrote. 'The Vaccines for Children (VFC) program continues to provide COVID-19 vaccines at no cost for eligible children when the parent, provider, and patient decide vaccination is appropriate. Medicaid will continue to reimburse the administration fee.' But the possibility that a vaccine could be restricted or no longer covered by insurance is already changing how parents approach immunization. In Falusi's practice, parents are scheduling appointments to coincide precisely with their child's eligibility, sometimes making appointments the same week as their birthdays. Melissa Mason, a pediatrician in Albuquerque, New Mexico, has evaluated some patients who contracted measles during the multistate outbreak that started in neighboring Texas. She's concerned that any new limitations on access or reimbursement for childhood vaccines could lead to even more preventable illnesses and deaths. Nationally, there have been more than 1,300 measles cases since January, including three deaths, according to the CDC. 'We're seeing this outbreak because vaccination rates are too low and it allows measles to spread in the community,' Mason said. Children and teens account for 66% of national measles cases. Mason has begun offering the measles vaccine to infants as young as 6 months old, a full six months earlier than standard practice, though still within federal guidelines. Last year, overall kindergarten vaccination rates fell in the U.S. At the same time, the number of children with a school vaccination exemption continued to rise. Pertussis, or whooping cough — another disease that can be deadly to young children — is spreading. As of July 5, more than 15,100 cases had been identified in U.S. residents this year, according to the CDC. Mason said pertussis is especially dangerous to babies too young to receive the vaccine. For now, pediatricians are trying to maintain a sense of urgency without inciting panic. In Columbia, South Carolina, Greenhouse used to offer families a flexible age range for routine vaccinations. 'I'm not saying that anymore,' the pediatrician said. She now urges parents to get their children vaccinated as soon as they are eligible. She described anxious parents asking whether the HPV vaccine, which helps prevent cervical cancer, can be administered to children younger than the recommended age of 9. 'I actually had two parents today ask if their 7- or 8-year-olds could get the HPV shot,' Greenhouse said. 'I had to tell them it's not allowed.' With the vaccine requiring multiple doses months apart, Greenhouse fears time may run out for families to get the series covered by insurance. If they have to pay out-of-pocket, she's afraid some families may choose not to get the second dose. A second dose could cost about $300 if no longer covered by insurance. 'I cannot be 100% sure what the future looks like for some of these vaccines,' Greenhouse said. 'I can tell you it's a very scary place to be.' Kennedy's newly appointed vaccine advisory committee is expected to hold its next public meeting as soon as August. KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store